Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.0157M
March 31, 2026 0.012M
December 31, 2025 15.52M
September 30, 2025 0.0061M
June 30, 2025 0.0113M
March 31, 2025 0.0136M
December 31, 2024 0.0116M
September 30, 2024 0.0137M
June 30, 2024 0.012M
March 31, 2024 0.0177M
December 31, 2023 0.0184M
September 30, 2023 0.0068M
June 30, 2023 0.0142M
March 31, 2023 0.0157M
December 31, 2022 0.011M
September 30, 2022 1.755M
June 30, 2022 -0.0369M
March 31, 2022 0.0415M
December 31, 2021 2.846M
September 30, 2021 0.0016M
June 30, 2021 1.145M
March 31, 2021 0.0238M
December 31, 2020
September 30, 2020
June 30, 2020
Date Value
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Biomerica, Inc. 0.871M
Lantheus Holdings, Inc. 4.505M
Zomedica Corp. 0.00
IDEXX Laboratories, Inc. -325.19M
Neogen Corp. -0.30M

Cash from Financing (Quarterly) Related Metrics